Literature DB >> 11986120

Informed consent and the capacity for voluntarism.

Laura Weiss Roberts1.   

Abstract

OBJECTIVE: Informed consent is built upon the elements of information, decisional capacity, and volunteerism. Of these elements, voluntarism in clinical and research consent is the least well understood. This has interfered with the ability to resolve key ethical problems faced by the field of psychiatry.
METHOD: The author suggests that voluntarism encompasses an individual's ability to act in accordance with one's authentic sense of what is good, right, and best in light of one's situation, values, and prior history. Voluntarism further entails the capacity to make this choice freely and in the absence of coercion. Deliberateness, purposefulness of intent, clarity, genuineness, and coherence with prior life decisions are implicitly emphasized in this construction.
RESULTS: The author offers and illustrates a framework for voluntarism in clinical and research consent decisions, focusing on four domains of potential influence: 1) developmental factors, 2) illness-related considerations, 3) psychological issues and cultural and religious values, and 4) external features and pressures.
CONCLUSIONS: It is hoped that improved understanding of voluntarism will help in our efforts to fulfill the principle of respect for persons in clinical care and research.

Entities:  

Keywords:  Biomedical and Behavioral Research; Professional Patient Relationship

Mesh:

Year:  2002        PMID: 11986120     DOI: 10.1176/appi.ajp.159.5.705

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

1.  A time of promise, a time of promises: ethical issues in advancing psychopharmacological research.

Authors:  Laura Weiss Roberts; John Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-11-13       Impact factor: 4.530

2.  Willingness of subjects with thought disorder to participate in research.

Authors:  Philip J Candilis; Cynthia M A Geppert; Kenneth E Fletcher; Charles W Lidz; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 3.  Evidence-based ethics for neurology and psychiatry research.

Authors:  Scott Y H Kim
Journal:  NeuroRx       Date:  2004-07

Review 4.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

5.  Attitudes Regarding Enrollment in a Genetic Research Project: An Informed Consent Simulation Study Comparing Views of People With Depression, Diabetes, and Neither Condition.

Authors:  Jane Paik Kim; Katie Ryan; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2019-07-22       Impact factor: 1.742

6.  Contextualising professional ethics: the impact of the prison context on the practices and norms of health care practitioners.

Authors:  Karolyn L A White; Christopher F C Jordens; Ian Kerridge
Journal:  J Bioeth Inq       Date:  2014-07-11       Impact factor: 1.352

Review 7.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

8.  Altruism in terminal cancer patients and rapid tissue donation program: does the theory apply?

Authors:  Gwendolyn P Quinn; Devin Murphy; Christie Pratt; Teresita Muñoz-Antonia; Lucy Guerra; Matthew B Schabath; Marino E Leon; Eric Haura
Journal:  Med Health Care Philos       Date:  2013-11

9.  Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Authors:  Laura B Dunn; Daniel S Kim; Ian E Fellows; Barton W Palmer
Journal:  Schizophr Bull       Date:  2008-02-14       Impact factor: 9.306

10.  Restoring balance: a consensus statement on the protection of vulnerable research participants.

Authors:  James M DuBois; Laura Beskow; Jean Campbell; Karen Dugosh; David Festinger; Sarah Hartz; Rosalina James; Charles Lidz
Journal:  Am J Public Health       Date:  2012-10-18       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.